Aliases & Classifications for Hemarthrosis

Aliases & Descriptions for Hemarthrosis:

Name: Hemarthrosis 12 52 42 14 69
Hemarthrosis Involving Pelvic Region and Thigh 12
Haemarthrosis of the Pelvic Region and Thigh 12
Hemarthrosis of the Pelvic Region and Thigh 12
Hemarthrosis Involving Shoulder Region 12
Hemarthrosis Involving Ankle and Foot 12
Hemarthrosis of the Ankle and/or Foot 12
Haemarthrosis of the Ankle and Foot 12
Hemarthrosis of the Shoulder Region 12
Hemarthrosis of the Ankle and Foot 12
Hemarthrosis of Ankle and/or Foot 12
Hemarthrosis Involving Lower Leg 12
Hemarthrosis Involving Upper Arm 12
Haemarthrosis of Shoulder Joint 12
Hemarthrosis of Shoulder Region 12
Hemarthrosis Involving Forearm 12
Hemarthrosis of the Lower Leg 12
Hemarthrosis of the Upper Arm 12
Hemarthrosis Involving Hand 12
Hemarthrosis of the Forearm 12
Hemarthrosis of Lower Leg 12
Hemarthrosis of Upper Arm 12
Hemarthrosis of Shoulder 12
Hemarthrosis of the Hand 12
Hemarthrosis of Forearm 12
Hemarthrosis of Hand 12

Classifications:



External Ids:

Disease Ontology 12 DOID:801
ICD10 33 M25.0
ICD9CM 35 719.1 719.10
MeSH 42 D006395
UMLS 69 C0018924

Summaries for Hemarthrosis

MalaCards based summary : Hemarthrosis, also known as hemarthrosis involving pelvic region and thigh, is related to myocardial infarction and factor x deficiency, and has symptoms including arthralgia, hemoptysis and metatarsalgia. An important gene associated with Hemarthrosis is F8 (Coagulation Factor VIII), and among its related pathways/superpathways are Metabolism of proteins and Response to elevated platelet cytosolic Ca2+. The drugs Bevacizumab and Hyaluronic acid have been mentioned in the context of this disorder. Affiliated tissues include bone, monocytes and myeloid, and related phenotypes are cardiovascular system and homeostasis/metabolism

Wikipedia : 71 Hemarthrosis (or haemarthrosis) is a bleeding into joint spaces. It is a common feature of Hemophilia.... more...

Related Diseases for Hemarthrosis

Diseases related to Hemarthrosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 100)
id Related Disease Score Top Affiliating Genes
1 myocardial infarction 29.1 F10 F7 F8 VWF
2 factor x deficiency 11.3
3 factor v deficiency 10.8
4 afibrinogenemia, congenital 10.8
5 factor vii deficiency 10.8
6 primary peritoneal carcinoma 10.2 F8 F9
7 acrodysplasia with ossification abnormalities, short stature and fibular hypoplasia 10.2 F8 F9
8 autonomic neuropathy 10.2 F8 F9
9 hemophilia 10.2
10 stroke, ischemic 10.1 F7 F8
11 social phobia 10.1 BGLAP F8
12 infiltrating ureter transitional cell carcinoma 10.1 F7 F8
13 serous cystadenocarcinoma 10.1 BGLAP SPP1
14 hypophosphatasia, adult 10.1 BGLAP SPP1
15 vaginal yolk sac tumor 10.1 F7 F9
16 retroperitoneal leiomyosarcoma 10.1 F7 F9
17 ovarian insufficiency due to fsh resistance 10.1 BGLAP SPP1
18 cranial nerve palsy 10.1 F8 F9
19 vcl-related familial hypertrophic cardiomyopathy 10.1 F8 VWF
20 vcp-related amyotrophic lateral sclerosis/frontotemporal dementia 10.1 F8 VWF
21 brill-zinsser disease 10.0 F7 F9
22 headache 10.0 F8 VWF
23 vcl-related dilated cardiomyopathy 10.0 F8 VWF
24 intra-abdominal lymph node mast cell malignancy 10.0 F7 SPP1
25 alpha-2-macroglobulin deficiency 10.0 F8 VWF
26 hypertrichosis 10.0 F8 VWF
27 spinocerebellar ataxia 27 10.0 F7 F8 F9
28 dysbaric osteonecrosis 10.0 BGLAP SPP1
29 renal adenoma 10.0 F8 VWF
30 von willibrand disease, type 3 10.0 F7 VWF
31 thyroid cancer, anaplastic 10.0 F8 VWF
32 acrodysplasia scoliosis 10.0 F10 F8 F9
33 atrophic nonflaccid tympanic membrane 10.0 F8 VWF
34 synovitis 10.0
35 leukocyte disease 10.0 F10 F9
36 deafness, autosomal recessive 79 9.9 SPP1 VWF
37 acromegaloid hypertrichosis syndrome 9.9 F8 F9 VWF
38 arthritis 9.9
39 pyridoxamine 5'-phosphate oxidase deficiency 9.9 F8 F9 VWF
40 giant papillary conjunctivitis 9.9 F8 F9 VWF
41 membranoproliferative glomerulonephritis 9.9 F8 F9 VWF
42 scurvy 9.8
43 bile duct mucoepidermoid carcinoma 9.8 SPP1 VWF
44 high anorectal malformation 9.8 F10 F8 VWF
45 aids dementia complex 9.8 F10 F8 VWF
46 immunodeficiency, common variable, 6 9.8 F10 F8 VWF
47 myeloproliferative neoplasm 9.8 F10 F8 VWF
48 hemophilia a 9.8
49 acute myocardial infarction 9.8
50 thrombasthenia 9.8

Graphical network of the top 20 diseases related to Hemarthrosis:



Diseases related to Hemarthrosis

Symptoms & Phenotypes for Hemarthrosis

UMLS symptoms related to Hemarthrosis:


arthralgia, hemoptysis, metatarsalgia, joint swelling, other symptoms referable to joint, stiffness of joint, not elsewhere classified in icd10cm

MGI Mouse Phenotypes related to Hemarthrosis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.35 F10 F7 F9 SPP1 VWF
2 homeostasis/metabolism MP:0005376 9.1 F10 F7 F8 F9 SPP1 VWF

Drugs & Therapeutics for Hemarthrosis

Drugs for Hemarthrosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 47)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bevacizumab Approved, Investigational Phase 4 216974-75-3
2
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
3
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
4
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
5
Benzocaine Approved Phase 4,Phase 3 1994-09-7, 94-09-7 2337
6 tannic acid Approved, Nutraceutical Phase 4,Phase 3
7 Angiogenesis Inhibitors Phase 4
8 Angiogenesis Modulating Agents Phase 4
9 Coagulants Phase 4,Phase 3,Phase 2
10 Factor VIII Phase 4,Phase 3,Phase 2
11 Adjuvants, Immunologic Phase 4
12 Hylan Phase 4
13 Protective Agents Phase 4
14 triamcinolone acetonide Phase 4
15 Triamcinolone diacetate Phase 4
16 Triamcinolone hexacetonide Phase 4
17 Viscosupplements Phase 4
18 Antibodies Phase 3
19 Immunoglobulin Fc Fragments Phase 3
20 Immunoglobulins Phase 3
21 Hemostatics Phase 3,Phase 2
22
Chlorhexidine Approved, Vet_approved 55-56-1 9552079 2713
23
Povidone-iodine Approved 25655-41-8
24
Bupivacaine Approved, Investigational 2180-92-9, 38396-39-3 2474
25
Epinephrine Approved, Vet_approved 51-43-4 5816
26 Chelating Agents
27 Chlorhexidine gluconate
28 Thrombin
29 Adrenergic Agents
30 Adrenergic Agonists
31 Adrenergic alpha-Agonists
32 Adrenergic beta-Agonists
33 Anesthetics
34 Anesthetics, Local
35 Anti-Asthmatic Agents
36 Autonomic Agents
37 Bronchodilator Agents
38 Central Nervous System Depressants
39 Epinephryl borate
40 Mydriatics
41 Narcotics
42 Neurotransmitter Agents
43 Peripheral Nervous System Agents
44 Racepinephrine
45 Respiratory System Agents
46 Vasoconstrictor Agents
47 Soy Bean Nutraceutical

Interventional clinical trials:

(show top 50) (show all 74)
id Name Status NCT ID Phase
1 Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis Unknown status NCT02060305 Phase 4
2 Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens Unknown status NCT02314325 Phase 4
3 Trial of NovoSeven® in Haemophilia - Joint Bleeds Completed NCT00108797 Phase 4
4 High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors Completed NCT00571584 Phase 4
5 Viscosupplementation in Patients With Hemophilic Arthropathy Completed NCT01748201 Phase 4
6 Russian Kogenate Pediatric Study Completed NCT00632814 Phase 4
7 BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) Completed NCT00586521 Phase 4
8 Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy Completed NCT00638001 Phase 4
9 Canadian Hemophilia Prophylaxis Study Completed NCT01085344 Phase 4
10 Prophylaxis Versus on Demand Treatment for Children With Hemophilia A Completed NCT01810666 Phase 4
11 Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A Completed NCT02697370 Phase 4
12 Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens Completed NCT00927667 Phase 4
13 A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A Children Recruiting NCT02999308 Phase 4
14 Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B Completed NCT00364182 Phase 3
15 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A Completed NCT01458106 Phase 3
16 Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B Completed NCT01440946 Phase 3
17 Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A Completed NCT01181128 Phase 3
18 Study to Determine the Safety and Efficacy of rFIXFc in Untreated Males With Severe Hemophilia B Recruiting NCT02234310 Phase 3
19 An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A Recruiting NCT02234323 Phase 3
20 A Study of Once-Weekly Emicizumab in Children and Adolescents With Hemophilia A and Factor VIII (FVIII) Inhibitors Active, not recruiting NCT02795767 Phase 3
21 A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors Active, not recruiting NCT02847637 Phase 3
22 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors Active, not recruiting NCT02622321 Phase 3
23 Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B Active, not recruiting NCT01425723 Phase 3
24 BAX 855 PK-Guided Dosing Active, not recruiting NCT02585960 Phase 3
25 A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A Active, not recruiting NCT01580293 Phase 2, Phase 3
26 Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A Enrolling by invitation NCT01454739 Phase 3
27 Early Prophylaxis Immunologic Challenge (EPIC) Study Terminated NCT01376700 Phase 3
28 rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors Unknown status NCT01105546 Phase 2
29 Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds Completed NCT00486278 Phase 2
30 Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII Completed NCT00245245 Phase 2
31 A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy Recruiting NCT02994147 Phase 2
32 BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A Terminated NCT00623727 Phase 2
33 Individualized Prophylaxis for Severe Hemophilia A Children Unknown status NCT02116855
34 The Effect of Functional Activities and Balance Ability With Taping in Subjects of Hemophilia Unknown status NCT02389205
35 Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait. Unknown status NCT02229331
36 Musculoskeletal Function in Hemophilia Unknown status NCT00324493
37 Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors Completed NCT01234545
38 The FEIBA NovoSeven Comparative Study Completed NCT00166309
39 Efficacy of Peroperative Suction Drain Usage in Arthroscopic Knee Surgery Completed NCT02752581
40 Physiotherapy in the Haemophilic Arthropathy of the Elbow. Completed NCT02198040
41 Manual Therapy in Haemophilic Arthropathy of the Knee Completed NCT02198014
42 The Von Willebrand Disease (VWD) International Prophylaxis Study Completed NCT00557908
43 Multidisciplinary Evaluation of Patients With Hemophilia Completed NCT02198430
44 Gait Evaluation in Haemophiliac Patients Completed NCT00824798
45 Educational Physiotherapy in Haemophilia Completed NCT02825706
46 Bilateral Deficit Phenomenon in Patients With Haemophilic Arthropathy Completed NCT02165462
47 Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy Completed NCT02601170
48 Prophylaxis Versus On-demand Therapy Through Economic Report Completed NCT01159587
49 Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia Completed NCT01988532
50 Aspiration for Pain Relief Following Ankle Fracture Completed NCT01484535

Search NIH Clinical Center for Hemarthrosis

Cochrane evidence based reviews: hemarthrosis

Genetic Tests for Hemarthrosis

Anatomical Context for Hemarthrosis

MalaCards organs/tissues related to Hemarthrosis:

39
Bone, Monocytes, Myeloid, B Cells, Skeletal Muscle

Publications for Hemarthrosis

Articles related to Hemarthrosis:

(show top 50) (show all 224)
id Title Authors Year
1
Endovascular Management of Recurrent Spontaneous Hemarthrosis After Arthroplasty. ( 27882429 )
2017
2
Spontaneous Recurrent Hemarthrosis of the Knee: A Report of Two Cases with a Source of Bleeding Detected during Arthroscopic Surgery of the Knee Joint. ( 27703824 )
2016
3
Reducing Intra-articular Hemarthrosis After Arthroscopic ACL Reconstruction: Response. ( 26929179 )
2016
4
Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis. ( 28039188 )
2016
5
Effects of hemarthrosis on cartilage and synovium in rabbits. ( 26936196 )
2016
6
Acute Hemarthrosis of the Knee Caused by Arteriovenous Malformation. ( 27231206 )
2016
7
Epidemiology of intra- and peri-articular structural injuries in traumatic knee joint hemarthrosis - data from 1145 consecutive knees with subacute MRI. ( 27374877 )
2016
8
Technically Successful Geniculate Artery Embolization Does Not Equate Clinical Success for Treatment of Recurrent Knee Hemarthrosis after Knee Surgery. ( 26806692 )
2016
9
Geniculate Artery Embolization for Management of Recurrent Hemarthrosis: A Single-Center Experience. ( 27338503 )
2016
10
Reducing Intra-articular Hemarthrosis After Arthroscopic ACL Reconstruction: Letter to the Editor. ( 26929178 )
2016
11
Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data. ( 25729030 )
2015
12
Geniculate artery embolization for recurrent postarthroplasty hemarthrosis of the knee. ( 27398122 )
2015
13
Reducing Intra-articular Hemarthrosis After Arthroscopic Anterior Cruciate Ligament Reconstruction by the Administration of Intravenous Tranexamic Acid: A Prospective, Randomized Controlled Trial. ( 26337246 )
2015
14
Recurrent Hemarthrosis Following Knee Arthroplasty Treated with Arterial Embolization. ( 26092252 )
2015
15
LASER versus electromagnetic field in treatment of hemarthrosis in children with hemophilia. ( 26306883 )
2015
16
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. ( 24418945 )
2014
17
Anticoagulant-induced hemarthrosis presenting as anterior shoulder dislocation. ( 25043625 )
2014
18
Occult Intra-articular Knee Injuries in Children With Hemarthrosis. ( 24753236 )
2014
19
Spontaneous hemarthrosis following fibrinolytic therapy for acute myocardial infarction: a case report and literature review. ( 25417208 )
2014
20
Recurrent hemarthrosis after total knee arthroplasty caused by the impingement of a remnant lateral meniscus: A case report. ( 24231622 )
2013
21
Hemophilic chronic synovitis: therapy of hemarthrosis using endovascular embolization of knee and elbow arteries. ( 23150120 )
2013
22
Selective arterial embolization with gelatin particles for refractory knee hemarthrosis. ( 23846552 )
2013
23
Geniculate artery embolization in the management of spontaneous recurrent hemarthrosis of the knee: case series. ( 23433418 )
2013
24
Recurrent hemarthrosis : an unusual cause. ( 23680622 )
2013
25
Hemarthrosis in hemophilic mice results in alterations in M1-M2 monocyte/macrophage polarization. ( 24252538 )
2013
26
A case of selective arterial embolization for recurrent hemarthrosis after total knee arthroplasty. ( 22237971 )
2013
27
Antiplasmin, but not amiloride, prevents synovitis and cartilage damage following hemarthrosis in hemophilic mice. ( 24283895 )
2013
28
A case of bilateral hemarthrosis due to pseudoaneurysms in a patient on anticoagulation therapy. ( 23669803 )
2013
29
Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis)--a cross-sectional analysis. ( 22874525 )
2012
30
MRI findings in adolescent patients with acute traumatic knee hemarthrosis. ( 23147616 )
2012
31
Intra-articular nodular fasciitis of the knee: a rare cause of recurrent hemarthrosis. ( 21431289 )
2012
32
Knee hemarthrosis after arthroscopic surgery in an athlete with low factor XIII activity. ( 23031577 )
2012
33
Transarterial embolization for the management of hemarthrosis of the knee. ( 22154590 )
2012
34
Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin. ( 22764328 )
2012
35
Spontaneous recurrent hemarthrosis of the knee joint in the elderly: a report of two cases. ( 21607723 )
2012
36
Recurrent hemarthrosis in a boy with synovial hemangioma: a case report. ( 21088622 )
2011
37
Magnetic resonance angiography in the management of recurrent hemarthrosis after total knee arthroplasty. ( 21397454 )
2011
38
Trauma resulting in hemarthrosis and long medial collateral ligament desmitis of the tarsocrural joint in a horse. ( 22043073 )
2011
39
Does the source of hemarthrosis influence posttraumatic joint contracture and biomechanical properties of the joint? ( 21420211 )
2011
40
Recurrent hemarthrosis after unicompartmental knee arthroplasty. ( 21902161 )
2011
41
A rare case of meniscal hematoma with hemarthrosis of the knee: a case report. ( 21938355 )
2011
42
Late recurrent hemarthrosis following knee arthroplasty associated with epithelioid angiosarcoma of bone. ( 19945286 )
2010
43
Recurrent hemarthrosis after total knee arthroplasty. ( 20076944 )
2010
44
Synovial hypertrophy causing recurrent hemarthrosis after total knee replacement. ( 20812578 )
2010
45
Spontaneous recurrent hemarthrosis of the knee joint in elderly patients with osteoarthritis: an infrequent presentation of synovial lipoma arborescens. ( 20526580 )
2010
46
Glanzmann thrombasthenia detected because of knee hemarthrosis: a case report. ( 20736850 )
2010
47
Recurrent hemarthrosis in a hemophilic patient after revision total knee arthroplasty. ( 20954656 )
2010
48
Angiographic findings and therapeutic embolization of late hemarthrosis after total joint arthroplasty. ( 18773205 )
2009
49
Isolation and characterization of connective tissue progenitor cells derived from human fracture-induced hemarthrosis in vitro. ( 17763429 )
2008
50
Spontaneous recurrent hemarthrosis of the knee in the elderly: arthroscopic treatment and etiology. ( 18760210 )
2008

Variations for Hemarthrosis

Expression for Hemarthrosis

Search GEO for disease gene expression data for Hemarthrosis.

Pathways for Hemarthrosis

Pathways related to Hemarthrosis according to GeneCards Suite gene sharing:

(show all 11)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.3 BGLAP F10 F7 F8 F9
2
Show member pathways
12.8 F10 F7 F8 F9 VWF
3
Show member pathways
12.39 F10 F7 F8 F9
4
Show member pathways
11.76 F10 F7 F8 F9 VWF
5
Show member pathways
11.59 BGLAP F10 F7 F9
6 11.5 F10 F7 F8 F9 VWF
7 11.48 BGLAP SPP1
8 11.13 BGLAP SPP1
9 11.09 BGLAP SPP1
10 11 BGLAP SPP1
11 10.1 BGLAP F10 F7 F9

GO Terms for Hemarthrosis

Cellular components related to Hemarthrosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.72 BGLAP F7 F8 F9 SPP1
2 extracellular region GO:0005576 9.7 BGLAP F10 F7 F8 F9 SPP1
3 vesicle GO:0031982 9.43 BGLAP F7 SPP1
4 platelet alpha granule lumen GO:0031093 9.37 F8 VWF
5 Golgi lumen GO:0005796 9.26 BGLAP F10 F7 F9
6 endoplasmic reticulum lumen GO:0005788 9.1 BGLAP F10 F7 F8 F9 SPP1

Biological processes related to Hemarthrosis according to GeneCards Suite gene sharing:

(show all 14)
id Name GO ID Score Top Affiliating Genes
1 blood coagulation GO:0007596 9.8 F10 F7 F8 F9 VWF
2 proteolysis GO:0006508 9.78 F10 F7 F8 F9
3 ER to Golgi vesicle-mediated transport GO:0006888 9.72 BGLAP F10 F7 F8 F9
4 signal peptide processing GO:0006465 9.56 BGLAP F10 F7 F9
5 positive regulation of protein kinase B signaling GO:0051897 9.54 F10 F7
6 blood coagulation, extrinsic pathway GO:0007598 9.54 F10 F7 F9
7 response to estrogen GO:0043627 9.52 BGLAP F7
8 response to nutrient levels GO:0031667 9.51 BGLAP F7
9 biomineral tissue development GO:0031214 9.49 BGLAP SPP1
10 response to vitamin D GO:0033280 9.46 BGLAP SPP1
11 blood coagulation, intrinsic pathway GO:0007597 9.46 F10 F8 F9 VWF
12 response to vitamin K GO:0032571 9.43 BGLAP F7
13 peptidyl-glutamic acid carboxylation GO:0017187 9.26 BGLAP F10 F7 F9
14 hemostasis GO:0007599 9.02 F10 F7 F8 F9 VWF

Molecular functions related to Hemarthrosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 calcium ion binding GO:0005509 9.46 BGLAP F10 F7 F9
2 endopeptidase activity GO:0004175 9.32 F7 F9
3 glycoprotein binding GO:0001948 9.26 F7 VWF
4 serine-type peptidase activity GO:0008236 9.13 F10 F7 F9
5 serine-type endopeptidase activity GO:0004252 8.92 F10 F7 F8 F9

Sources for Hemarthrosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....